JABLX | RLBFX | JABLX / RLBFX | |
Total Expense Ratio | 0.62 | 0.29 | 214% |
Annual Report Gross Expense Ratio | 0.62 | 0.29 | 214% |
Fund Existence | 32 years | 23 years | - |
Gain YTD | 9.957 | 14.743 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.52B | 267B | 4% |
Annual Yield % from dividends | 1.94 | 2.00 | 97% |
Returns for 1 year | 10.15 | 9.41 | 108% |
Returns for 3 years | 53.64 | 53.56 | 100% |
Returns for 5 years | 44.45 | 43.76 | 102% |
Returns for 10 years | 122.39 | 79.88 | 153% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DXD | 22.08 | 0.24 | +1.10% |
ProShares UltraShort Dow30 | |||
IROC | 50.65 | 0.03 | +0.06% |
Invesco Rochester High Yield Municipal ETF | |||
BMEZ | 14.94 | -0.06 | -0.40% |
BlackRock Health Sciences Term Trust | |||
OAIM | 40.06 | -0.34 | -0.85% |
OneAscent International Equity ETF | |||
MST | 8.20 | -0.51 | -5.86% |
Defiance Leveraged Long + Inc MSTR ETF |